Introduction
-
Second most prevalent cause of cancer death in women
-
Most breast cancers originate in mammary ducts
Types of Breast Cancer
-
In situ breast carcinoma is noninvasive. There are two types: ductal and lobular.
-
Infiltrating carcinoma is invasive carcinoma. It can originate in the ducts or lobules of the breast, but has spread to the surrounding connective tissue.
Risk Factors
-
A history of breast cancer greatly increases the risk for future development of breast cancer.
-
It is possible to inherit defective genes that lead to the familial form of breast cancer.
-
Breast cancer risk increases with age.
-
African Americans women have a lower risk of developing breast cancer compared to white American women.
-
Hormone replacement therapy has been associated with increased breast cancer risk, but its impact is still under investigation.
-
Exposure to radiation and dietary factors also affect breast cancer risk.
Pathology Report and Staging
-
A sample of breast tissue is examined micro- and macroscopically in order to create a pathology report.
-
The T/N/M system is one of the most common methods used for breast cancer staging.
-
The T/N/M system assigns a degree of severity based on size, lymph node involvement, and spread of the cancer.
Breast Cancer Tumor Biology
-
Many genetic changes occur in cancer. Details can be found in the Mutation section.
-
BRCA1, BRCA2, HER-2, PTEN, TP53, and ATM are all genes involved in breast cancer development.
-
The estrogen receptor protein binds estrogen in the cell. This complex promotes cell division. The presence or absence of this protein helps determine treatment option for the cancer.
Treatment
-
Treatments differ by the stage of the cancer.
-
Early stage treatment involves cancers confined to the breast.
-
Late stage treatment involves tumors that have spread beyond the breast.
-
Treatments can include: surgery, radiation therapy, chemotherapy, hormone therapy, and targeted treatments.
Breast Cancer in Men
-
Male breast cancer is rare and usually occurs later in men than women.
-
The process of detection, diagnosis, and treatment is similar to those of female breast cancer.
Triple Negative Breast Cancer
-
The cancer does not produce significant amounts of estrogen receptor, progesterone receptor, or a form of the epidermal growth factor receptor (HER2).
-
Triple negative breast cancer tends to be an aggressive cancer.
-
Triple negative breast cancer is unresponsive to the available targeted treatments.